Get started
SAMRAT PHARMACHEM LTD.SAMRAT PHARMACHEM LTD.SAMRAT PHARMACHEM LTD.

SAMRAT PHARMACHEM LTD.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

SAMRATPH chart


Full chart

Key stats


Market capitalization
‪1.15 B‬ INR
Dividend yield (indicated)
0.27%
Price to earnings Ratio (TTM)
12.85
Basic EPS (TTM)
28.85 INR
Net income (FY)
‪21.63 M‬ INR
Revenue (FY)
‪2.82 B‬ INR
Shares float
—
Beta (1Y)
1.03

Employees


Employees (FY)
32
Change (1Y)
+3 +10.34%
Revenue / Employee (1Y)
‪87.99 M‬ INR
Net income / Employee (1Y)
‪675.81 K‬ INR

About SAMRAT PHARMACHEM LTD.


Sector
Process Industries
Industry
Chemicals: Specialty
CEO
Lalit Damodar Mehta
Website
samratpharmachem.com
Headquarters
Mumbai
Founded
1992
ISIN
INE103E01016
FIGI
BBG000F74529
Samrat Pharmachem Ltd. engages in the manufacturing manufacturing and selling chemicals. Its products include 3-5–Di iodosalicylic acid, aluminium iodide, clioquinol, ethylenediamine dihydroiodide, copper iodine, and lithium iodide. The company was founded by Lalit Damodar Mehta on June 16, 1992, and is headquartered in Mumbai, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

SAMRATPH news



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as SAMRATPH.

Frequently Asked Questions


The current price of SAMRATPH is 379.05 INR — it has increased by 2.18% in the past 24 hours. Watch SAMRAT PHARMACHEM LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange SAMRAT PHARMACHEM LTD. stocks are traded under the ticker SAMRATPH.
SAMRATPH stock has fallen by −4.28% compared to the previous week, the month change is a 8.94% rise, over the last year SAMRAT PHARMACHEM LTD. has showed a 4.71% increase.
SAMRATPH reached its all-time high on Sep 20, 2022 with the price of 1,250.00 INR, and its all-time low was 2.15 INR and was reached on Nov 5, 2003. View more price dynamics on SAMRATPH chart.
See other stocks reaching their highest and lowest prices.
SAMRATPH stock is 2.51% volatile and has beta coefficient of 1.03. Track SAMRAT PHARMACHEM LTD. stock price on the chart and check out the list of the most volatile stocks — is SAMRAT PHARMACHEM LTD. there?
Today SAMRAT PHARMACHEM LTD. has the market capitalization of ‪1.15 B‬, it has increased by 11.11% over the last week.
Yes, you can track SAMRAT PHARMACHEM LTD. financials in yearly and quarterly reports right on TradingView.
SAMRATPH net income for the last quarter is ‪27.85 M‬ INR, while the quarter before that showed ‪26.61 M‬ INR of net income which accounts for 4.64% change. Track more SAMRAT PHARMACHEM LTD. financial stats to get the full picture.
Yes, SAMRATPH dividends are paid annually. The last dividend per share was 1.00 INR. As of today, Dividend Yield (TTM)% is 0.27%. Tracking SAMRAT PHARMACHEM LTD. dividends might help you take more informed decisions.
SAMRAT PHARMACHEM LTD. dividend yield was 0.30% in 2023, and payout ratio reached 14.29%. The year before the numbers were 0.27% and 1.86% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 22, 2025, the company has 32 employees. See our rating of the largest employees — is SAMRAT PHARMACHEM LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SAMRAT PHARMACHEM LTD. EBITDA is ‪114.71 M‬ INR, and current EBITDA margin is 1.00%. See more stats in SAMRAT PHARMACHEM LTD. financial statements.
Like other stocks, SAMRATPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SAMRAT PHARMACHEM LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SAMRAT PHARMACHEM LTD. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SAMRAT PHARMACHEM LTD. stock shows the sell signal. See more of SAMRAT PHARMACHEM LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.